Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This synthetic peptide resembles the actions of naturally produced GLP-1, a hormone that plays a crucial role in regulating blood sugar concentrations. By activating GLP-1 receptors in the pancreas, Retasturtide